Concepedia

B. E. Huber

BE

Statistics

Publications

2

Citations

302

H-Index

2

Active since

1987

Affiliations

GlaxoSmithKline (United States)(Current)

B. E. Huber is an author at GlaxoSmithKline (United States) specializing in liver cancer, hepatic tumors, and molecular oncology.

Publications per year

1987–2001

2

Publications

2

Expression of the Multidrug-Resistant Gene in Hepatocarcinogenesis and Regenerating Rat Liver

S.S. Thorgeirsson, B. E. Huber, Susan H. Sorrell et al. · Science · 1987 · 274 citations

, , +14

Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases

M.J. Humphreys, Paula Ghaneh, William Greenhalf et al. · Gene Therapy · 2001 · 28 citations

, , +16

1–2 of 2